Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nexalin Technology logo — Treatments for anxiety and insomnia without medication

Nexalin Technology

Treatments for anxiety and insomnia without medication

Founded 2010 United States Houston, United States 22 employees Post-IPO Equity Total: $5.75M Hardware

General Information

Company Name Nexalin Technology
Founded Year 2010
Location United States Houston, United States
Founders / Decision Makers
Team member
Employees 22
Industries Hardware
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Nexalin Technology. To contact Nexalin Technology, visit nexalin.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nexalin Technology compare?

A PDF of Nexalin Technology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nexalin Technology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nexalin Technology

Nexalin Technology is a U.S.-based startup offering non-invasive and drug-free therapy for anxiety, depression, and insomnia. The company's patented waveform, Transcranial Electrical Stimulation (TES), has shown significant increase in beta-endorphins in clinical trials, demonstrating its efficacy. This technology has received FDA approval and is classified as a non-significant risk device, underlining its safety and reliability. The therapy's long-lasting effects have been attributed to its ability to normalize neurochemistry and influence various neurochemical levels in the brain, including neuropeptides, neurotransmitters, and neuromodulators. Nexalin Technology, established in 2010, operates in the hardware industry and received a $501.71K Venture Round investment in August 2011. The company's focus on leveraging innovative technology to address critical mental health issues offers potential for substantial growth and impact in the healthcare industry. This underscores the significant market potential for non-pharmaceutical treatment alternatives, positioning Nexalin Technology as an attractive investment opportunity in the rapidly evolving mental wellness sector.

Business keywords: transcranial electrical stimulation, anxiety treatment, insomnia treatment, non-invasive therapy, FDA approved, neurochemistry normalization, depression treatment, neurochemical influence, beta-endorphins, hypothalamus stimulation, brain structure adaptation, non-drug therapy, health technology, clinical trials

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $5.25M -
27 Jun 2024
Venture Round $501.71K -
09 Aug 2011

Nexalin Technology Alternatives & Competitors

View All Alternatives
Nexalin Technology vs
Fisher Wallace Laboratories, Inc.
Fisher Wallace Laboratories, Inc. United States

Better tech for mental health.

Venture round
12 employees
Hardware, Manufacturing
Nexalin Technology vs
Soterix Medical
Soterix Medical United States

Engineering Serving Humanity

Grant
36 employees
Biotechnology, Hardware
Nexalin Technology vs
Cala Health
Cala Health United States

A bioelectronic medicine company transforming the standard of care for chronic disease.

Series D
121 employees
Hardware, Health Care
View all alternatives

FAQ About Nexalin Technology

Treatments for anxiety and insomnia without medication
Nexalin Technology was founded in 2010.
Nexalin Technology is headquartered in Houston, United States.
Nexalin Technology operates in Hardware. Its work centres on transcranial electrical stimulation, anxiety treatment, insomnia treatment and non-invasive therapy.
Nexalin Technology has approximately 22 employees.
Nexalin Technology has completed 2 funding rounds, raising a total of $5.75M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Nexalin Technology include Fisher Wallace Laboratories, Inc., Soterix Medical, Cala Health, Avation Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nexalin Technology and Fisher Wallace Laboratories, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nexalin Technology, https://bouncewatch.com/company/nexalin-technology, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes